Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Löw

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Seminars in Neurology|March 17, 2018
Primary Central Nervous System LymphomaSarah Löw, Tracy T Batchelor
Therapeutic Advances in Neurological Disorders|October 12, 2018
Primary central nervous system lymphomaSarah Löw, Catherine H Han, Tracy T Batchelor
Anticancer Research|February 5, 2009
Pathogenetic pathways leading to glioblastoma multiforme: association between gene expressions and resistance to erlotinibSarah Löw, Vassilios I Vougioukas, Thomas Hielscher, et al.
Anticancer Research|February 5, 2009
Epidermal growth factor receptor pathway gene expressions and biological response of glioblastoma multiforme cell lines to erlotinibMarce E Halatsch, Sarah Löw, Thomas Hielscher, et al.
Journal of Neurosurgery|March 24, 2009
Candidate genes for sensitivity and resistance of human glioblastoma multiforme cell lines to erlotinib. Laboratory investigationMarc-Eric Halatsch, Sarah Löw, Kay Mursch, et al.
Journal of Neuro-Oncology|March 6, 2021
Prophylactic anticoagulation in patients with glioblastoma or brain metastases and atrial fibrillation: an increased risk for intracranial hemorrhage?Sina Burth, Mona Ohmann, Dorothea Kronsteiner, et al.
Neuro-Oncology|June 15, 2016
Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastomaSina Burth, Philipp Kickingereder, Oliver Eidel, et al.
Oncotarget|July 23, 2016
Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin? Induction of oxidative stress in murine glioblastoma therapyDieter Lemke, Hans-Werner Pledl, Markus Zorn, et al.
Frontiers in Oncology|January 24, 2019
Palliative Radiotherapy for Leptomeningeal Carcinomatosis-Analysis of Outcome, Prognostic Factors, and Symptom ResponseRami A El Shafie, Karina Böhm, Dorothea Weber, et al.
Journal of Neurochemistry|July 1, 2014
Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?Dieter Lemke, Markus Weiler, Jonas Blaes, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Seminars in Neurology|March 17, 2018
Primary Central Nervous System LymphomaSarah Löw, Tracy T Batchelor
Therapeutic Advances in Neurological Disorders|October 12, 2018
Primary central nervous system lymphomaSarah Löw, Catherine H Han, Tracy T Batchelor
Anticancer Research|February 5, 2009
Pathogenetic pathways leading to glioblastoma multiforme: association between gene expressions and resistance to erlotinibSarah Löw, Vassilios I Vougioukas, Thomas Hielscher, et al.
Anticancer Research|February 5, 2009
Epidermal growth factor receptor pathway gene expressions and biological response of glioblastoma multiforme cell lines to erlotinibMarce E Halatsch, Sarah Löw, Thomas Hielscher, et al.
Journal of Neurosurgery|March 24, 2009
Candidate genes for sensitivity and resistance of human glioblastoma multiforme cell lines to erlotinib. Laboratory investigationMarc-Eric Halatsch, Sarah Löw, Kay Mursch, et al.
Journal of Neuro-Oncology|March 6, 2021
Prophylactic anticoagulation in patients with glioblastoma or brain metastases and atrial fibrillation: an increased risk for intracranial hemorrhage?Sina Burth, Mona Ohmann, Dorothea Kronsteiner, et al.
Neuro-Oncology|June 15, 2016
Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastomaSina Burth, Philipp Kickingereder, Oliver Eidel, et al.
Oncotarget|July 23, 2016
Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin? Induction of oxidative stress in murine glioblastoma therapyDieter Lemke, Hans-Werner Pledl, Markus Zorn, et al.
Frontiers in Oncology|January 24, 2019
Palliative Radiotherapy for Leptomeningeal Carcinomatosis-Analysis of Outcome, Prognostic Factors, and Symptom ResponseRami A El Shafie, Karina Böhm, Dorothea Weber, et al.
Journal of Neurochemistry|July 1, 2014
Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?Dieter Lemke, Markus Weiler, Jonas Blaes, et al.
Pageof 2